Several options can help restore sexual desire during and after menopause, ranging from testosterone therapy and prescription medications to vaginal treatments and lifestyle changes. The most effective approach depends on what’s driving the drop in libido, whether that’s hormonal shifts, vaginal discomfort making sex painful, or a combination of both.
Why Libido Drops During Menopause
Declining estrogen is the change most associated with menopause, but testosterone also decreases steadily from your 20s onward. By the time you reach menopause, your testosterone levels are roughly half what they were at their peak. Since testosterone plays a central role in sexual desire for all genders, this gradual decline often translates to noticeably lower interest in sex.
On top of hormonal changes, menopause brings vaginal dryness, thinning tissue, and discomfort during intercourse, a cluster of symptoms now called genitourinary syndrome of menopause. When sex becomes painful, desire naturally follows downward. Sleep disruption, mood changes, and hot flashes pile on further. Effective treatment often means addressing more than one of these layers at once.
Testosterone Therapy
Testosterone is the most studied and most consistently effective treatment for low sexual desire in postmenopausal women. A global consensus statement published in the Journal of Clinical Endocrinology & Metabolism supports its use specifically for this purpose, while noting that no formulation is officially approved for women in most countries. In practice, doctors prescribe male testosterone gels or creams at one-tenth the male dose, typically starting at about 5 mg per day applied to the skin and increasing to 10 mg if needed.
The evidence is strong enough that international guidelines recommend trying it when low desire causes significant personal distress and other contributing factors have been addressed. If you don’t notice improvement within six months, guidelines recommend stopping. Safety data from clinical trials show no serious adverse events at these low doses, though the longest studies only extend to about two years. Your doctor will check testosterone blood levels every six months to make sure concentrations stay within the normal range for women. Pellet implants and injections that push levels above normal are specifically not recommended.
Potential side effects at appropriate doses are mild: occasional acne or unwanted hair growth. These are signs the dose may be too high and typically resolve with adjustment.
Estrogen-Based Hormone Therapy
Standard menopausal hormone therapy with estrogen (with or without progesterone) has a more indirect effect on desire. A large meta-analysis covering nearly 3,000 women found that estrogen therapy produced only a small improvement in overall sexual function scores. The benefit appears to come mainly from reducing the symptoms that interfere with sex, like vaginal dryness, hot flashes, and disrupted sleep, rather than from directly boosting desire itself.
That said, if painful intercourse or severe night sweats are the main reasons your interest in sex has dropped, treating those problems with hormone therapy can make a real difference. For many women, removing the barriers to comfortable sex is enough to bring desire back on its own.
Tibolone
Tibolone is a synthetic hormone available in many countries outside the United States that acts like a combination of estrogen, progesterone, and testosterone in the body. In clinical trials of late postmenopausal women, tibolone significantly improved desire, arousal, lubrication, and the ability to reach orgasm while reducing pain during intercourse. It appears to have an edge over conventional hormone therapy specifically for desire and arousal, likely because of its testosterone-like activity.
Vaginal DHEA (Prasterone)
Prasterone is a vaginal insert containing DHEA, a hormone your body converts locally into both estrogen and testosterone right in the vaginal tissue. This dual action sets it apart from vaginal estrogen alone. In a 12-week trial of postmenopausal women, the effective dose improved desire by 23% to 49% compared to placebo, depending on the questionnaire used. Arousal improved by up to 68%, orgasm by 75%, and dryness during intercourse by 57%.
What makes prasterone particularly appealing is that it works locally. Hormone levels in the bloodstream stay within the normal postmenopausal range, meaning the sexual benefits come without significant systemic hormone exposure. It is FDA-approved under the brand name Intrarosa for painful sex due to menopause, and its effects on desire appear to be a meaningful additional benefit.
Oral DHEA supplements, by contrast, have not shown reliable results. A systematic review of postmenopausal women with normal adrenal function found no statistically significant improvement in libido or sexual function from oral DHEA. The vaginal route is the one with solid evidence behind it.
Prescription Medications for Low Desire
Two medications are FDA-approved specifically for hypoactive sexual desire disorder (HSDD), defined as a persistent lack of sexual desire lasting at least six months that causes marked personal distress.
Flibanserin (Addyi) is a daily pill that works in the brain by adjusting the balance between serotonin, dopamine, and norepinephrine. In postmenopausal women, clinical trials showed statistically significant improvements in desire scores, number of satisfying sexual events per month, and reductions in sex-related distress. Women taking it were about 54% more likely than those on placebo to report meaningful personal benefit. The improvements are real but modest. You cannot drink alcohol while taking it due to a risk of severe low blood pressure, which limits its practicality for some women.
Bremelanotide (Vyleesi) works through a different pathway, activating receptors in the brain involved in sexual arousal. It’s a self-administered injection taken 45 minutes before anticipated sexual activity rather than daily. It was primarily studied in premenopausal women, and robust data specifically in postmenopausal populations are limited. Nausea is the most common side effect and tends to lessen with repeated use.
Both medications were designed for women whose low desire isn’t explained by relationship problems, other medications (like antidepressants), or untreated medical conditions. They work best when those factors have been ruled out first.
Maca Root
Among herbal options, maca root has the most consistent evidence in menopausal women, though the studies are small. Multiple clinical trials using 2 to 3.5 grams of maca powder daily found reductions in menopausal symptoms overall, including improvements in measures of sexual dysfunction, anxiety, and depression. Maca does not appear to work by changing estrogen or testosterone levels directly. Instead, it may improve well-being broadly enough that sexual interest benefits as a secondary effect.
Maca is generally well tolerated and widely available as a supplement. The evidence is encouraging but not nearly as robust as what exists for testosterone or prasterone. If you’re looking for something to try before pursuing prescription options, it’s a reasonable starting point, but expectations should be measured.
Pelvic Floor Strengthening
Pelvic floor muscle strength has a moderate positive correlation with libido, sexual satisfaction, and overall sexual function in perimenopausal women. In one study, women with stronger pelvic floor muscles were roughly 2.5 times less likely to experience sexual dysfunction. The relationship likely works in multiple directions: stronger muscles improve physical sensation during sex, reduce urinary leakage that can cause embarrassment, and may boost confidence and body awareness.
Pelvic floor physical therapy or a structured Kegel exercise program won’t replace hormonal treatment for severe desire problems, but it addresses a physical foundation that many women overlook. It pairs well with any of the hormonal or medical options above and carries no risks.
Putting the Options Together
The practical starting point depends on your symptoms. If vaginal dryness and painful intercourse are the main issues dampening your interest, vaginal prasterone or vaginal estrogen can resolve those directly, and desire often improves as a result. If your body feels fine but the mental spark is simply gone, testosterone therapy has the strongest evidence for restoring desire itself. Flibanserin or bremelanotide are alternatives when testosterone isn’t an option or hasn’t worked.
Many women benefit from combining approaches: systemic hormone therapy to manage hot flashes and sleep, a vaginal treatment for tissue health, and possibly testosterone on top of that for desire. Pelvic floor work and maca can complement any of these. The goal isn’t to find a single pill but to address the specific mix of physical, hormonal, and neurological factors that are getting in the way.